A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

Clinical trial NCT05411718 · RECRUITING

Trial details

NCT number: NCT05411718
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

T Cells Colorectal Cancer Lynch Syndrome

Start date: 2023-03-21
Primary completion: 2026-11-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.